Increased susceptibility to SARS-CoV-2 infection in patients with reduced left ventricular ejection fraction - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue ESC Heart Failure Année : 2021

Increased susceptibility to SARS-CoV-2 infection in patients with reduced left ventricular ejection fraction

Kensuke Matsushita
  • Fonction : Auteur
Benjamin Marchandot
  • Fonction : Auteur
Adrien Carmona
  • Fonction : Auteur
  • PersonId : 1118749
Anais Curtiaud
  • Fonction : Auteur
Anis El Idrissi
  • Fonction : Auteur
Antonin Trimaille
  • Fonction : Auteur
Marion Kibler
  • Fonction : Auteur
Thomas Cardi
  • Fonction : Auteur
Joe Heger
  • Fonction : Auteur
  • PersonId : 1214468
Sebastien Hess
  • Fonction : Auteur
Antje Reydel
  • Fonction : Auteur
Laurence Jesel
  • Fonction : Auteur
  • PersonId : 1118747
Patrick Ohlmann
  • Fonction : Auteur
  • PersonId : 1084292
Olivier Morel
  • Fonction : Auteur
  • PersonId : 1102510

Résumé

AIMS: Cardiovascular disease has been recognized as a major determinant of coronavirus disease 2019 (COVID-19) vulnerability and severity. Angiotensin-converting enzyme (ACE) 2 is a functional receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is up-regulated in patients with heart failure. We sought to examine the potential association between reduced left ventricular ejection fraction (LVEF) and the susceptibility to SARS-CoV-2 infection. METHODS AND RESULTS: Of the 1162 patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention between February 2014 and October 2018, we enrolled 889 patients with available clinical follow-up data. Follow-up was conducted by telephone interviews 1 month after the start of the French lockdown which began on 17 March 2020. Patients were divided into two groups according to LVEF <40% (reduced LVEF) (n = 91) or ≥40% (moderately reduced + preserved LVEF) (n = 798). The incidence of COVID-19-related hospitalization or death was significantly higher in the reduced LVEF group as compared with the moderately reduced + preserved LVEF group (9% vs. 1%, P < 0.001). No association was found between discontinuation of ACE-inhibitor or angiotensin-receptor blockers and COVID-19 test positivity. By multivariate logistic regression analysis, reduced LVEF was an independent predictor of COVID-19 hospitalization or death (odds ratio: 6.91, 95% confidence interval: 2.60 to 18.35, P < 0.001). CONCLUSIONS: In a large cohort of patients with previous ACS, reduced LVEF was associated with increased susceptibility to COVID-19. Aggressive COVID-19 testing and therapeutic strategies may be considered for patient with impaired heart function.
Fichier principal
Vignette du fichier
islandora_142606.pdf (806.76 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03944274 , version 1 (17-01-2023)

Identifiants

Citer

Kensuke Matsushita, Benjamin Marchandot, Adrien Carmona, Anais Curtiaud, Anis El Idrissi, et al.. Increased susceptibility to SARS-CoV-2 infection in patients with reduced left ventricular ejection fraction. ESC Heart Failure, 2021, 8 (1), pp.380-389. ⟨10.1002/ehf2.13083⟩. ⟨hal-03944274⟩

Collections

CNRS SITE-ALSACE
9 Consultations
12 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More